Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1991-4-22
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0007-0963
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
124
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
209-10
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:2004010-Adolescent,
pubmed-meshheading:2004010-Adult,
pubmed-meshheading:2004010-Autoimmune Diseases,
pubmed-meshheading:2004010-Female,
pubmed-meshheading:2004010-Humans,
pubmed-meshheading:2004010-Male,
pubmed-meshheading:2004010-Middle Aged,
pubmed-meshheading:2004010-Psoriasis,
pubmed-meshheading:2004010-Tumor Necrosis Factor-alpha
|
| pubmed:year |
1991
|
| pubmed:articleTitle |
Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis.
|
| pubmed:publicationType |
Letter,
Case Reports
|